VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Sanofi vs TransUnion
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Sanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
TransUnion
TRU · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Sanofi leads (74 / 100 vs 61 / 100 for TransUnion).
- Segment focus: Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)); TransUnion has 4 segments (34.2% in U.S. Markets - Financial Services).
- Moat breadth: Sanofi has 5 moat types across 3 domains; TransUnion has 8 across 4.
Primary market context
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
TransUnion
U.S. Markets - Financial Services
U.S. consumer credit bureau data & risk analytics for lenders
United States
B2B (banks, lenders, fintechs, mortgage/auto originators)
Consumer reporting agency & decisioning analytics provider
34.2%
Side-by-side metrics
Moat coverage
Shared moat types
Sanofi strengths
TransUnion strengths
Segment mix
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
TransUnion segments
Full profile >U.S. Markets - Financial Services
Oligopoly
U.S. Markets - Emerging Verticals
Competitive
U.S. Markets - Consumer Interactive
Competitive
International
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.